Skip to content
ARVO 2025

ARVO 2025

The ARVO 2025 Annual Meeting is just around the corner! Our teams from Finland, Lithuania, and France are getting ready for the trip to Salt Lake City.

Learn more Arrow right
Improving corneal permeability of dexamethasone using penetration enhancing agents: first step towards achieving topical drug delivery to the retina​​

Improving corneal permeability of dexamethasone using penetration enhancing agents: first step towards achieving topical drug delivery to the retina​​

To date, ocular injections and implants are the most effective methods for drug delivery to the back of the eye. However, invasive delivery methods also are costly and risky due to possible complications. In this paper, a novel proprietary polyacetylene polymer and two cell penetrating peptides are compared for topical drug delivery to treat retinal diseases.

Learn more Arrow right
ARVO 2024 presentation: Function-Structure Relationship in the Rat Glaucoma Model​​

ARVO 2024 presentation: Function-Structure Relationship in the Rat Glaucoma Model​​

Examining the link between retinal function and structure in ocular hypertension is crucial for glaucoma research. The rat magnetic microbead model, mimicking glaucoma aspects, provides insights into this relationship. The study aims to examine if behavioral, functional, and morphological parameters have correlation in the rat magnetic microbead glaucoma model.​

Learn more Arrow right
1 2 3
AAALAC accredited company

All our facilities are AAALAC accredited, reflecting our commitment to the highest standards of animal care in research.